The a2 Milk Company Limited (ACOPY) ist ein börsennotiertes Unternehmen im Defensiver Konsum Sektor, tätig in der Agricultural Farm Products Branche. Der Hauptsitz des Unternehmens ist in Auckland, New Zealand. Der aktuelle CEO ist David L. Bortolussi.
ACOPY hat IPO-Datum 2019-05-21, 488 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $4.2B.
The a2 Milk Company Limited is a dairy products company incorporated in New Zealand that produces and sells milk and infant formula made from A2 protein type cattle. The company markets its fresh milk products under the a2 Milk brand and infant formula under the a2 Platinum brand across multiple regions including Australia, New Zealand, China, other Asian countries, and the United States. Founded in 2000 and headquartered in Auckland, New Zealand, the company has positioned itself as a specialist in A2 protein dairy products, distinguishing itself from conventional dairy manufacturers. The company operates through subsidiaries to manage its global distribution and market presence across key developed and emerging markets.
